The global cardiac rehabilitation market was valued at $1,971.1 million in 2021 and is projected to reach $3,241.38 million by 2031 registering a CAGR of 5.1% from 2022 to 2031.
Cardiac rehab is a medically supervised program which is designed to improve patient’s cardiovascular health. It is customized outpatient program of exercise. Cardiac rehabilitation often involves exercise training to reduce heart disease risk. It is important for patients who are at higher risk of heart attack, heart failure, coronary artery bypass graft, and heart valve repair replacement. Cardiac rehabilitation program aims to limit the psychological stresses of cardiovascular disease and improve cardiovascular function to help patients achieve their highest quality of life possible. Cardiac rehab gives the information which is required in everyday life about heart disorders. These equipment/devices help recover from cardiovascular surgery and heart attack.
The main factors that foster the growth of the cardiac rehabilitation market are rise in cases of cardiovascular disease, and increase in adoption of tele-cardiac rehabilitation to minimize barriers for time, distance and cost. Along with this, a number of factors such as a large number of technological advancements in cardiac rehab devices, increase in adoption rate of these therapies, and rise in emphasis on early intervention and primary prevention of heart-related disorders are responsible for driving the market growth. Moreover, rise in demand and adoption of finger-tip oximeter devices during the COVID-19 pandemic for continuous patient monitoring and launch of new finger-tip pulse oximeter by large number of key players are the major factors driving the market growth. Furthermore, as per Organization for Economic Co-operation and Development, in 2018, a total of 45,307 cases of coronary artery bypass grafting procedures were performed in Germany. Hence, the surge in incidences of emergency surgeries and extensive uses of cardiac rehabilitation devices post-surgery propel the growth of the cardiac rehabilitation market.
Moreover, development of pharmaceutical & medical device industries and improvement in healthcare spending are anticipated to drive the growth of the cardiac rehabilitation market. For instance, in January 2020, Omron Corporation has launched HeartGuide device. This device is a wearable cardiac rehabilitation product that monitor blood pressure. It enabled people to monitor their blood pressure wherever and whenever they want. It also helps to understand the fluctuation of blood pressure in day time and helps to get control over high blood pressure. Regular self-monitoring of blood pressure can significantly reduce the risk of cardiac disorders. Moreover, high demand from the U.S. and pre-order availability for HeartGuide led Omron to file more than 80 patents to develop HeartGuide in the design of wrist watch that ensures the accuracy and reliability. Thus, presence of innovative product lines fuels the growth of the cardiac rehabilitation market.
Furthermore, rise in geriatric population and increase in burden of cardiovascular diseases lead to rise in awareness regarding cardiac rehabilitation among people, which drive the growth of the market. Moreover, according to World Health Organization, 17.9 million people were estimated to die from cardiovascular disease in 2019. Thus, upsurge in burden of cardiovascular diseases and increased rate of heart failure are anticipated to boost the demand for cardiac rehabilitation. Furthermore, rise in number of product approvals is expected to provide remunerative opportunities for the expansion of the global market during the forecast period. Sedentary lifestyle makes people susceptible to having many disorders such as diabetes, and cardiovascular disorders. High blood pressure and diabetes are the two main factors responsible for the rise in number of heart failures. This disease is associated with high hospitalization rate and substantial cost due to frequent use of heart rate and blood pressure monitor devices. Thus, an increase in number of surgeries due to rise in cases of chronic diseases is expected to increase the adoption rate of cardiac rehabilitation products and increase the growth of the market.
However, high costs of cardiac rehabilitation products, limited availability of funds, and dearth of skilled professionals are the factors projected to impede the market growth. Presently, there is an increase in awareness regarding health among people, which, in turn, compels them to maintain their health condition and leads to rise in usage of home fitness devices. This has encouraged many key players to enter emerging market, thus offering lucrative growth opportunities in the cardiac rehabilitation market.
For the purpose of analysis cardiac rehabilitation market is studied across by product type, disease type, and end user. On the basis of product type the market is segmented into elliptical trainer, stabilization ball, treadmills, heart rate monitor, blood pressure monitor, rower, and others. By disease type, the market is divided into percutaneous coronary intervention, myocardial infraction, coronary artery bypass grafting, coronary artery disease, and others. By end user, it is categorized into rehab centers, hospitals, clinics, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players mentioned in the report are Baxter International Inc., Core Health & Fitness, LLC, GE Healthcare, Halma Plc, Johnson Health Tech, Koninklijke Philips N.V, Life Fitness, Omron Corporation, Smith Group, and Technogym.
Cardiac rehab is a medically supervised program which is designed to improve patient’s cardiovascular health. It is customized outpatient program of exercise. Cardiac rehabilitation often involves exercise training to reduce heart disease risk. It is important for patients who are at higher risk of heart attack, heart failure, coronary artery bypass graft, and heart valve repair replacement. Cardiac rehabilitation program aims to limit the psychological stresses of cardiovascular disease and improve cardiovascular function to help patients achieve their highest quality of life possible. Cardiac rehab gives the information which is required in everyday life about heart disorders. These equipment/devices help recover from cardiovascular surgery and heart attack.
The main factors that foster the growth of the cardiac rehabilitation market are rise in cases of cardiovascular disease, and increase in adoption of tele-cardiac rehabilitation to minimize barriers for time, distance and cost. Along with this, a number of factors such as a large number of technological advancements in cardiac rehab devices, increase in adoption rate of these therapies, and rise in emphasis on early intervention and primary prevention of heart-related disorders are responsible for driving the market growth. Moreover, rise in demand and adoption of finger-tip oximeter devices during the COVID-19 pandemic for continuous patient monitoring and launch of new finger-tip pulse oximeter by large number of key players are the major factors driving the market growth. Furthermore, as per Organization for Economic Co-operation and Development, in 2018, a total of 45,307 cases of coronary artery bypass grafting procedures were performed in Germany. Hence, the surge in incidences of emergency surgeries and extensive uses of cardiac rehabilitation devices post-surgery propel the growth of the cardiac rehabilitation market.
Moreover, development of pharmaceutical & medical device industries and improvement in healthcare spending are anticipated to drive the growth of the cardiac rehabilitation market. For instance, in January 2020, Omron Corporation has launched HeartGuide device. This device is a wearable cardiac rehabilitation product that monitor blood pressure. It enabled people to monitor their blood pressure wherever and whenever they want. It also helps to understand the fluctuation of blood pressure in day time and helps to get control over high blood pressure. Regular self-monitoring of blood pressure can significantly reduce the risk of cardiac disorders. Moreover, high demand from the U.S. and pre-order availability for HeartGuide led Omron to file more than 80 patents to develop HeartGuide in the design of wrist watch that ensures the accuracy and reliability. Thus, presence of innovative product lines fuels the growth of the cardiac rehabilitation market.
Furthermore, rise in geriatric population and increase in burden of cardiovascular diseases lead to rise in awareness regarding cardiac rehabilitation among people, which drive the growth of the market. Moreover, according to World Health Organization, 17.9 million people were estimated to die from cardiovascular disease in 2019. Thus, upsurge in burden of cardiovascular diseases and increased rate of heart failure are anticipated to boost the demand for cardiac rehabilitation. Furthermore, rise in number of product approvals is expected to provide remunerative opportunities for the expansion of the global market during the forecast period. Sedentary lifestyle makes people susceptible to having many disorders such as diabetes, and cardiovascular disorders. High blood pressure and diabetes are the two main factors responsible for the rise in number of heart failures. This disease is associated with high hospitalization rate and substantial cost due to frequent use of heart rate and blood pressure monitor devices. Thus, an increase in number of surgeries due to rise in cases of chronic diseases is expected to increase the adoption rate of cardiac rehabilitation products and increase the growth of the market.
However, high costs of cardiac rehabilitation products, limited availability of funds, and dearth of skilled professionals are the factors projected to impede the market growth. Presently, there is an increase in awareness regarding health among people, which, in turn, compels them to maintain their health condition and leads to rise in usage of home fitness devices. This has encouraged many key players to enter emerging market, thus offering lucrative growth opportunities in the cardiac rehabilitation market.
For the purpose of analysis cardiac rehabilitation market is studied across by product type, disease type, and end user. On the basis of product type the market is segmented into elliptical trainer, stabilization ball, treadmills, heart rate monitor, blood pressure monitor, rower, and others. By disease type, the market is divided into percutaneous coronary intervention, myocardial infraction, coronary artery bypass grafting, coronary artery disease, and others. By end user, it is categorized into rehab centers, hospitals, clinics, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The key players mentioned in the report are Baxter International Inc., Core Health & Fitness, LLC, GE Healthcare, Halma Plc, Johnson Health Tech, Koninklijke Philips N.V, Life Fitness, Omron Corporation, Smith Group, and Technogym.
KEY BENEFITS FOR STAKEHOLDERS
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the cardiac rehabilitation market analysis from 2021 to 2031 to identify the prevailing cardiac rehabilitation market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the cardiac rehabilitation market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global cardiac rehabilitation market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
- Elliptical Trainer
- Stabilization ball
- Treadmill
- Heart rate monitor
- Blood pressure monitor
- Rower
- Others
By Disease Type
- Percutaneous Coronary Intervention
- Myocardial Infarction
- Coronary Artery Bypass Grafting
- Coronary Artery Disease
- Others
By End User
- Rehab Centers
- Hospitals
- Clinics
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Halma plc.
- Life Fitness
- GE Healthcare
- Smiths Group
- Koninklijke Philips N.V.
- Omron Corporation
- Technogym
- Core Health & Fitness, LLC
- Baxter
- Johnson Health Tech.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: CARDIAC REHABILITATION MARKET, BY PRODUCT
CHAPTER 5: CARDIAC REHABILITATION MARKET, BY DISEASE TYPE
CHAPTER 6: CARDIAC REHABILITATION MARKET, BY END USER
CHAPTER 7: CARDIAC REHABILITATION MARKET, BY REGION
CHAPTER 8: COMPANY LANDSCAPE
CHAPTER 9: COMPANY PROFILES
List of Tables
List of Figures
Executive Summary
According to the report, titled, “Cardiac Rehabilitation Market," the cardiac rehabilitation market size was valued at $1.97 billion in 2021, and is estimated to reach $3.24 billion by 2031, growing at a CAGR of 5.1% from 2022 to 2031.Cardiac rehabilitation comprises three equal important parts such as exercise counselling and training, education for healthy heart living, and counselling to reduce stress. Cardiac rehab helps to identify everyday sources of stress. If a person have a heart attack and other heart problem cardiac rehabilitation is best part of recovery. It helps prevent serious heart attack and can help build healthy-heart habits. Cardiac rehabilitation has many health benefits such as reliving symptoms of heart problems, such as chest pain, preventing future illness and deaths from heart disease. Cardiac rehabilitation programs focus on blood pressure management, diabetes management, exercise training, and physical activity counselling. Cardiac rehabilitation increases the quality of life and decreases health care costs.
Surge in popularity of e-cardiology and e-health is one of the major factors, which boost the cardiac rehabilitation market growth. In addition, the medical device sector has opened new approaches and collaborations in the industry to respond to the urgent needs of the pandemic. For instance, according to the Center for Disease Control and Prevention data reviewed on January 10, 2022, more than 868,000 Americans experienced death due to heart diseases, and more than 34.2 died due to diabetes. According to the International Diabetes Federation, in 2021, approximately 537 million adults were living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2045. Thus, rise in burden of cardiovascular diseases increases the demand for portable monitoring devices, which is anticipated to foster the growth of the cardiac rehabilitation market.
In addition, according to Center for Disease Control and Prevention in 2019, around 360,900 people were estimated to have died with coronary artery heart disease in the U.S. Out of this, 18.2 million were 20 year old adults. These aforementioned factors increase the demand for cardiac rehabilitation escalating the growth of the market.
Increase in government support for management of heart diseases and surge in demand for effective prevention treatment are some of the major cardiac rehabilitation market trends. In addition, key players, such as Baxter International Inc., Philips N.V, Smits Group and Life fitness provide the cardiac rehabilitation equipment and contribute toward the market growth. Rise in demand for cardiac rehabilitation for post-cardio surgery acts a key driving force for the expansion of the global cardiac rehabilitation market.
However, high cost of acquisition and maintenance of cardiac rehabilitation equipment and shortage of skilled professionals to operate equipment are some key challenges that hinder the growth of the market. On the contrary, increase in number of medical devices manufacturing plants surge the demand for home use cardiac rehabilitation devices creating an opportunity for the manufacturers to tap and capitalize on the market.
For the purpose of analysis cardiac rehabilitation market is studied across by product type, disease type, and end user. On the basis of product type the market is segmented into elliptical trainer, stabilization ball, treadmills, heart rate monitor, blood pressure monitor, rower, and others. By disease type, the market is divided into percutaneous coronary intervention, myocardial infraction, coronary artery bypass grafting, coronary artery disease, and others. By end user, it is categorized into rehab centers, hospitals, clinics, and others. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
By product type, the treadmill segment dominated the global market in 2021 and is anticipated to remain dominant during the forecast period. This is attributed to rise in awareness among people about health consciousness. In addition, the blood pressure monitors segment is expected to register higher CAGR during the forecast period owing to rise in focus on monitoring blood pressure at home care settings.
On the basis of disease type, the coronary artery disease segment acquired the largest share in 2021, and is expected to remain dominant throughout the forecast period. This is attributed to the increase in number of heart disease patients. By end user, it is categorized into rehab centers, hospitals, clinics and others. The rehab centers acquired the largest share in 2021, and is expected to remain dominant throughout the forecast period. This is attributed to the increase in number of heart disease patients and surge in number of hospital admissions.
By region, the cardiac rehabilitation industry is analyzed across North America, Europe, Asia-Pacific, and LAMEA. By region, North America accounted for the largest share of the global cardiac rehabilitation market in 2021, and is expected to remain dominant throughout the forecast period. This was attributed to the presence of giant biopharmaceutical and medical device companies in the countries such as the U.S. In addition, increase in frequency of major pharmaceutical companies and their R&D activities drive the demand for cardiac rehabilitation in the region during the forecast period.
Key Findings of the Study
- By product, the treadmill segment was the highest contributor to the market in 2021.
- By disease type, the coronary artery disease segment was the highest contributor to the market in 2021.
- By end user, the rehab centers segment dominates the growth of the market.
- North America accounted for a majority of the cardiac rehabilitation market share in 2021, and is anticipated to remain dominant during the forecast period.
Companies Mentioned
- Halma plc.
- Life Fitness
- Ge Healthcare
- Smiths Group
- Koninklijke Philips N.V.
- Omron Corporation
- Technogym
- Core Health & Fitness, LLC
- Baxter
- Johnson Health Tech.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 269 |
| Published | July 2022 |
| Forecast Period | 2021 - 2031 |
| Estimated Market Value ( USD | $ 1971.1 million |
| Forecasted Market Value ( USD | $ 3241.38 million |
| Compound Annual Growth Rate | 5.1% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
